GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0001649 | Colorectum | AD | osteoblast differentiation | 70/3918 | 229/18723 | 3.59e-04 | 4.18e-03 | 70 |
GO:0051047 | Colorectum | AD | positive regulation of secretion | 90/3918 | 310/18723 | 4.11e-04 | 4.66e-03 | 90 |
GO:1903532 | Colorectum | AD | positive regulation of secretion by cell | 82/3918 | 282/18723 | 6.85e-04 | 7.00e-03 | 82 |
GO:0015833 | Colorectum | AD | peptide transport | 77/3918 | 264/18723 | 8.90e-04 | 8.60e-03 | 77 |
GO:0090087 | Colorectum | AD | regulation of peptide transport | 60/3918 | 202/18723 | 1.94e-03 | 1.58e-02 | 60 |
GO:0030072 | Colorectum | AD | peptide hormone secretion | 68/3918 | 236/18723 | 2.39e-03 | 1.85e-02 | 68 |
GO:0002791 | Colorectum | AD | regulation of peptide secretion | 59/3918 | 200/18723 | 2.50e-03 | 1.92e-02 | 59 |
GO:0090276 | Colorectum | AD | regulation of peptide hormone secretion | 58/3918 | 196/18723 | 2.51e-03 | 1.92e-02 | 58 |
GO:0002790 | Colorectum | AD | peptide secretion | 69/3918 | 242/18723 | 2.97e-03 | 2.22e-02 | 69 |
GO:0042886 | Colorectum | AD | amide transport | 83/3918 | 301/18723 | 3.37e-03 | 2.46e-02 | 83 |
GO:0120162 | Colorectum | AD | positive regulation of cold-induced thermogenesis | 32/3918 | 97/18723 | 3.74e-03 | 2.63e-02 | 32 |
GO:0002792 | Colorectum | AD | negative regulation of peptide secretion | 17/3918 | 44/18723 | 5.46e-03 | 3.56e-02 | 17 |
GO:0106106 | Colorectum | AD | cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
GO:0120161 | Colorectum | AD | regulation of cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
GO:0001503 | Colorectum | AD | ossification | 106/3918 | 408/18723 | 7.68e-03 | 4.64e-02 | 106 |
GO:1990845 | Colorectum | AD | adaptive thermogenesis | 46/3918 | 157/18723 | 7.97e-03 | 4.73e-02 | 46 |
GO:00016491 | Colorectum | SER | osteoblast differentiation | 56/2897 | 229/18723 | 2.49e-04 | 4.21e-03 | 56 |
GO:0051051 | Colorectum | SER | negative regulation of transport | 98/2897 | 470/18723 | 1.01e-03 | 1.19e-02 | 98 |
GO:00158331 | Colorectum | SER | peptide transport | 58/2897 | 264/18723 | 3.08e-03 | 2.70e-02 | 58 |
GO:00900871 | Colorectum | SER | regulation of peptide transport | 46/2897 | 202/18723 | 3.86e-03 | 3.18e-02 | 46 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FFAR4 | SNV | Missense_Mutation | novel | c.271G>A | p.Ala91Thr | p.A91T | Q5NUL3 | protein_coding | tolerated(0.22) | possibly_damaging(0.793) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | novel | c.1102A>C | p.Lys368Gln | p.K368Q | Q5NUL3 | protein_coding | deleterious(0.01) | benign(0.036) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD |
FFAR4 | SNV | Missense_Mutation | | c.872N>A | p.Ile291Asn | p.I291N | Q5NUL3 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | rs138801183 | c.838C>T | p.Arg280Cys | p.R280C | Q5NUL3 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AX-A3G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | novel | c.976N>C | p.Thr326Pro | p.T326P | Q5NUL3 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | | c.454N>T | p.Arg152Trp | p.R152W | Q5NUL3 | protein_coding | tolerated(0.16) | benign(0.013) | TCGA-BG-A0LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | novel | c.796N>G | p.Ser266Gly | p.S266G | Q5NUL3 | protein_coding | tolerated(0.13) | benign(0.061) | TCGA-BK-A4ZD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | | c.946C>T | p.Pro316Ser | p.P316S | Q5NUL3 | protein_coding | tolerated(0.26) | benign(0.285) | TCGA-D1-A160-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | novel | c.1111N>T | p.Asp371Tyr | p.D371Y | Q5NUL3 | protein_coding | deleterious(0) | possibly_damaging(0.781) | TCGA-DF-A2KV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FFAR4 | SNV | Missense_Mutation | novel | c.354G>A | p.Met118Ile | p.M118I | Q5NUL3 | protein_coding | tolerated(0.33) | benign(0.1) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 252166628 | | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 178100239 | | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 178102223 | | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 178102222 | | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 178102224 | | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135651531 | | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135650341 | GW9508 | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135651503 | | |
338557 | FFAR4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135651436 | | |